Company: Seegene Incorporated

Bloomberg ticker: 096530 KS

Market cap: US$4,675m

Background: Seegene, Incorporated is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents, e.g., in-vitro diagnostics tests that can detect disease, conditions and infections. In vitro means “in glass,” which means the tests are typically conducted in test tubes and similar equipment. Seegene has also developed an All-in-One platform to streamline the whole testing process.

World Class Benchmarking of Seegene Inc

---

---

 

• Profitable Growth rank of 1 was same compared to the prior period’s 1st rank
• This is World Class performance compared to 370 large Health Care companies worldwide
• Profitability rank of 1 was the same as its Growth rank of 1
• Profitability rank of 1 was up compared to the prior period’s 2nd rank
• This is World Class performance compared to peers
• Growth rank of 1 was the same compared to the prior period’s 1st rank
• This is World Class performance compared to peers

 

---

DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.